Can the DDT-related metabolite DDA indicate persistent endocrine-disrupting exposure?

Exposure to the organochlorine pesticide DDT leads to prolonged internal exposure and endocrine disruption through its metabolic products. While some metabolites are cleared rapidly, others accumulate in biological tissues over a lifetime.

Metabolic pathway and tissue persistence

• Biotransformation to DDA: In mammalian systems, DDT is metabolized in the liver via reductive dechlorination to dichlorodiphenyldichloroethane (DDD), which undergoes oxidative side-chain degradation to form 2,2-bis(4-chlorophenyl)acetic acid (DDA). As a polar, water-soluble terminal metabolite, DDA is readily excreted in urine and serves as a biomarker of recent exposure.
• Adipose sequestration: Alternatively, DDT undergoes dehydrochlorination to form dichlorodiphenyldichloroethylene (DDE). Unlike DDA, DDE is highly lipophilic and sequesters in adipose tissue with an exceptional biological half-life of 8 to 15 years (compared to 4 to 10 years for parent DDT). Due to this persistence, older individuals (aged 60 and above) typically exhibit the highest cumulative body burdens of DDE.

Mechanisms of endocrine disruption

• Estrogen receptor modulation: The isomer o,p′-DDT acts as a direct estrogen receptor-alpha (ERα) agonist. It competitively inhibits estradiol binding and stimulates ER-dependent cellular proliferation, with effective concentrations in the low-to-mid micromolar range (1–10 µM).
• Androgen receptor antagonism: The highly persistent metabolite p,p′-DDE opposes endocrine signaling by acting as a potent androgen receptor (AR) antagonist. It competes for androgen binding and suppresses androgen-induced transcriptional activity, exhibiting a binding/competition IC50 of approximately 5 µM and a Ki of 3.5 µM.

Bottom line

• DDT-related organochlorines disrupt endocrine signaling through dual pathways: o,p′-DDT acts as an estrogen receptor agonist, while its highly persistent, adipose-sequestered metabolite p,p′-DDE serves as a potent androgen receptor antagonist.